Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 08/3/15 → 02/18/17 |
Funding
- Gilead Sciences Incorporated: $7,600.00
A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Dose Ranging, Parallel Group Study to Evaluate the Effect of GS-6615 on Ventricular Arrhythmia in Subjects with Implantable Cardioverter-Defibrillator(ICD)or Cardiac Resynchronization
- Rashba, Eric (PI)
- Almasry, Ibrahim (CoPI)
- Fan, Roger (CoPI)
- Barbera, Saverio (CoPI)
Project: Research